#222 AFib Stroke Prevention: WATCHMAN, DOACs, and the CHAMPION-AF Trial | Beyond Journal Club Segment with NEJM Group

OCT 28, 202631 MIN

Description

If your patient asks you about a left atrial appendage closure device, what should you tell them?    In the latest episode of the Beyond Journal Club podcast from CORE IM and NEJM Group, the hosts will help you:  Understand the trade-offs: stroke prevention, bleeding, procedural risks, and medications afterward.  Build clinical judgment: weigh which approach may better serve the individual patient, beyond the trial’s headline.  Learn from thoughtful counseling: hear how you might discuss the evidence, acknowledge uncertainty, and explore what matters to your patients. 🔹Sponsor: ACP MKSAP Oakstone CME Use the code "CORE25" for 25% off: https://www.coreimpodcast.com/MKSAP7​ 🔹Transcript and Show Notes   01:09 | What the Watchman is, and why it should work? 05:58 | The checkered history: PROTECT-AF and PREVAIL 09:06 | The plot continues: PRAGUE-17, OPTION, OCEAN, and CLOSURE-AF 12:35 | CHAMPION-AF: the biggest test yet 15:03 | Reading the fine print 19:23 | A local solution to a systemic problem 22:45 | How patients hear about it 25:44 | So what do we tell our patients? 29:52 | Takeaways Tags: IMCore, Internal Medicine, Medical Education, WATCHMAN device, Atrial Fibrillation, Cardiology, DOAC Anticoagulation, Primary Care, Hospital Medicine Find the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840 Our Sponsors: * Check out Eko: https://ekohealth.com * Check out FIGS and use my code FIGSRX for a great deal: https://wearfigs.com Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy